GenPAx is a biotechnology company enabling next-generation precision medicine to fight pathogens. GenPAx will provide fast, high definition, affordable data analysis of bacteria genome sequence data globally. GenPAx aims to provide clinics, laboratories and hospitals with vital infection control information in order to derive solutions to contain, treat and eradicate threats to mankind.
Biotechnology, Science, Bacterial
No funding announced yet
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as GenPAx? We’re happy to assist you with our Startup Sourcing service.